X, formerly known as Twitter, is in trouble again with advertisers after Elon Musk’s latest controversial tweet.
Pfizer
The U.S. Food and Drugs Administration has granted approval for Pfizer's RSV vaccines designed for pregnant women.
The Biden administration plans to urge citizens to get booster shots for the COVID XBB.1.5 subvariant this autumn to counter a new wave.
Pfizer Inc and its German partner BioNTech SE on Tuesday filed an application with U.S. regulators seeking emergency use authorization for a second booster shot of their COVID-19 vaccine for people aged 65 and older. The submission to the U.S. Food and Drug Administration includes data collected in Israel, where a second booster is authorized […]
U.S. health authorities again expanded the nation’s booster campaign Thursday, opening extra doses of Pfizer’s COVID-19 vaccine to several million 16- and 17-year-olds. The U.S. and many other nations already were urging adults to get booster shots to pump up immunity that can wane months after vaccination, calls that intensified with the discovery of the […]
The European Union’s drug regulator on Thursday authorized Pfizer’s coronavirus vaccine for use on children from 5 to 11 years old, clearing the way for shots to be administered to millions of elementary school pupils amid a new wave of infections sweeping across the continent. It is the first time the European Medicines Agency has […]
Kid-size doses of Pfizer’s COVID-19 vaccine appear safe and nearly 91% effective at preventing symptomatic infections in 5- to 11-year-olds, according to study details released Friday as the U.S. considers opening vaccinations to that age group. The shots could begin in early November — with the first children in line fully protected by Christmas — […]
The U.S. Food and Drug Administration (FDA) finally authorized on Wednesday Pfizer and BioNTech vaccine booster dose against COVID-19’s delta variant for Americans aged 65 and older with a high risk of grave illness. While the dose will strictly involve a specific population group, boosters will be accessible to individuals between 18 and 64 years […]